Results 201 to 210 of about 1,057,849 (262)

Exploring the Potential of Stem Cells: A Systematic Review on Cellular Therapy for Sensorineural Hearing Loss. [PDF]

Cureus
Henao Rincón MA, Pulido Arias EA, Pachon Rojas C, Gonzalez Orozco A, Bolaños Lopez C, Arango García V, Uribe Escobar A, Velez Duncan CA.   +7 more
europepmc   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy. [PDF]

Sci Immunol
Maurer K, Park CY, Mani S, Borji M, Raths F, Gouin KH, Penter L, Jin Y, Zhang JY, Shin C, Brenner JR, Southard J, Krishna S, Lu W, Lyu H, Abbondanza D, Mangum C, Olsen LR, Lawson MJ, Fabani M, Neuberg DS, Bachireddy P, Glezer EN, Farhi SL, Li S, Livak KJ, Ritz J, Soiffer RJ, Wu CJ, Azizi E.   +29 more
europepmc   +1 more source

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

Molecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic, Anne Nørremølle, Lilian Bomme Ousager, Lars van Brakel Andersen, Marie Louise Mølgaard Binderup, Mads Thomassen   +5 more
wiley   +1 more source

CRISPR/Cas9-mediated PD-1 attenuation enhances tumor infiltrating lymphocyte-based adoptive cellular therapy in humanized-PDX model of hepatocellular carcinoma. [PDF]

Transl Oncol
Ge W, Liu H, Wu D, Hu Y, Liang Q, Liu M, Liu H, Wu J, Zhang J, Deng Y, Ghimire K, Rong P, Wang W, Ma X.   +13 more
europepmc   +1 more source

Transplantation and Cellular Therapy for Older Adults-The MSK Approach. [PDF]

Curr Hematol Malig Rep
Lin RJ, Dahi PB, Korc-Grodzicki B, Shahrokni A, Jakubowski AA, Giralt SA.   +5 more
europepmc   +1 more source

Management of <i>Clostridioides difficile</i> infection in patients with haematological malignancies and after cellular therapy: guidelines from 10th European Conference on Infections in Leukaemia (ECIL-10). [PDF]

EClinicalMedicine
Mikulska M, Robin C, Neofytos D, Oltolini C, Piekarska A, Reigadas E, Gil L, Chemaly RF, Groll AH, Muñoz P, Teh BW.   +10 more
europepmc   +1 more source

Cellular therapy for traumatic brain injury in adults: a meta-analysis of controlled clinical trials. [PDF]

Arch Med Sci
Alizada M, Lin S, Wu J, Alizada M, Ngwayi JRM, Alizada M, Gao H.   +6 more
europepmc   +1 more source

Obesity and Outcomes in Adoptive Cellular Therapy in Solid Tumors.

JAMA Netw Open
Tao DL, Nardo M, Leung CH, Lin HY, Kang L, Le H, Dumbrava EE, Hong DS.   +7 more
europepmc   +1 more source

Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network. [PDF]

Blood Adv
Battiwalla M, Tees M, Flinn I, Pantin J, Berdeja J, Gregory T, Maris M, Bhushan V, Vance E, Mathews J, Bachier C, Shaughnessy P, Ramakrishnan A, Malik S, Mori S, Martin C, Billups R, Blunk B, LeMaistre CF, Majhail NS.   +19 more
europepmc   +1 more source